• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与对比剂肾病无关。

Obesity is not associated with contrast nephropathy.

机构信息

Section of Nephrology, VA Loma Linda Healthcare System.

出版信息

Ther Clin Risk Manag. 2010 May 25;6:213-7. doi: 10.2147/tcrm.s10198.

DOI:10.2147/tcrm.s10198
PMID:20526376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2878954/
Abstract

BACKGROUND

Exposure to radiocontrast media may result in acute kidney injury (AKI) or traditionally defined contrast nephropathy (CN), both of which may lead to increased morbidity and mortality. The pathogenesis of both these variants of contrast-induced nephropathy (CIN) may involve inflammatory mediators that lead to renal impairment. A link between obesity and inflammation has been clearly established, but whether obesity is independently associated with CIN is unknown.

OBJECTIVE

To determine whether obesity, when stratified by body mass index (BMI), is a risk factor for CIN in a large and hemodynamically stable population of hospitalized United States veterans.

DESIGN

Retrospective chart review.

MEASUREMENTS

Presence or absence of AKI or CN after intravenous radiocontrast administration and comparison of patient characteristics between those with versus without AKI or CN.

RESULTS

The overall prevalence of AKI and CN was 16.1% and 12.6%, respectively. Patients with AKI or CN were comparable to those without radiocontrast injury, except that affected patients tended to be older and diabetic. When stratified by BMI, obesity was not found to be associated with the development of AKI or CN after exposure to radiocontrast.

CONCLUSION

Obesity does not appear to be an independent risk factor for AKI or CN after exposure to radiocontrast.

摘要

背景

接触造影剂可能导致急性肾损伤(AKI)或传统定义的造影剂肾病(CN),两者均可导致发病率和死亡率增加。这两种造影剂诱导的肾病(CIN)变体的发病机制都可能涉及导致肾功能损害的炎症介质。肥胖与炎症之间的联系已经得到明确证实,但肥胖是否与 CIN 独立相关尚不清楚。

目的

确定肥胖(按体重指数(BMI)分层)是否是美国住院退伍军人这一大且血流动力学稳定人群中 CIN 的危险因素。

设计

回顾性图表审查。

测量

静脉内造影剂给药后 AKI 或 CN 的存在或不存在,并比较有 AKI 或 CN 与无 AKI 或 CN 患者的特征。

结果

AKI 和 CN 的总体患病率分别为 16.1%和 12.6%。发生 AKI 或 CN 的患者与未发生造影剂损伤的患者相似,只是受影响的患者年龄更大且患有糖尿病。按 BMI 分层时,肥胖与接触造影剂后发生 AKI 或 CN 无关。

结论

肥胖似乎不是接触造影剂后发生 AKI 或 CN 的独立危险因素。

相似文献

1
Obesity is not associated with contrast nephropathy.肥胖与对比剂肾病无关。
Ther Clin Risk Manag. 2010 May 25;6:213-7. doi: 10.2147/tcrm.s10198.
2
Estimating the Risk of Radiocontrast-Associated Nephropathy.评估放射性造影剂相关性肾病的风险。
J Am Soc Nephrol. 2017 Feb;28(2):653-659. doi: 10.1681/ASN.2016010021. Epub 2016 Sep 29.
3
Contrast-Induced Acute Kidney Injury: Evidence in Support of Its Existence and a Review of Its Pathogenesis and Management.对比剂诱导的急性肾损伤:支持其存在的证据及其发病机制与管理的综述
Int J Nephrol Renovasc Dis. 2022 Oct 11;15:253-266. doi: 10.2147/IJNRD.S371700. eCollection 2022.
4
Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.动脉内与静脉内造影剂对比和慢性肾脏病中的肾损伤:倾向匹配分析。
Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26.
5
Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.对比剂肾病与心脏手术后急性肾损伤和死亡风险。
Ann Thorac Surg. 2012 Sep;94(3):772-6. doi: 10.1016/j.athoracsur.2012.04.089. Epub 2012 Jul 25.
6
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.尼可地尔治疗对预防接受心脏导管插入术的高危患者造影剂肾病的疗效:一项前瞻性随机对照试验。
Cardiol J. 2017;24(5):502-507. doi: 10.5603/CJ.a2017.0028. Epub 2017 Mar 10.
7
Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?在急诊科,对于非创伤性急腹症患者,对比剂诱导的肾病风险是否真的是进行静脉对比增强计算机断层扫描的禁忌证?
Acta Biomed. 2018 Dec 17;89(9-S):158-172. doi: 10.23750/abm.v89i9-S.7891.
8
Radiocontrast-induced nephropathy: an update.放射性造影剂所致肾病:最新进展
Minerva Urol Nefrol. 2009 Sep;61(3):215-33.
9
Recent advances in the prevention of radiocontrast-induced nephropathy.预防放射性造影剂所致肾病的最新进展
Curr Opin Crit Care. 2004 Dec;10(6):505-9. doi: 10.1097/01.ccx.0000145098.13199.e8.
10
Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.住院儿科患者行增强 CT 检查后发生急性肾损伤的风险:倾向评分分析。
Radiology. 2020 Mar;294(3):548-556. doi: 10.1148/radiol.2020191931. Epub 2020 Jan 21.

引用本文的文献

1
Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography.肥胖患者在对比增强计算机断层扫描冠状动脉造影后发生对比剂诱导的急性肾损伤不可逆性的预测因素
Adv Ther. 2025 Jan;42(1):293-309. doi: 10.1007/s12325-024-03036-z. Epub 2024 Nov 11.
2
Perirenal Fat Thickness Is Associated With Contrast-Induced Nephropathy in Type 2 Diabetic Patients Undergoing Coronary Catheterization.肾周脂肪厚度与行冠状动脉造影检查的 2 型糖尿病患者造影剂肾病相关。
J Diabetes Res. 2024 Aug 22;2024:4905669. doi: 10.1155/2024/4905669. eCollection 2024.
3
Magnitude and associated factors of contrast induced nephropathy among patients undergoing coronary angiography and interventions at a cardiac referral hospital in Tanzania - a cross-sectional study.坦桑尼亚一家心脏转诊医院接受冠状动脉造影和介入治疗的患者中造影剂肾病的发生率及相关因素——一项横断面研究。
Pan Afr Med J. 2021 Mar 29;38:311. doi: 10.11604/pamj.2021.38.311.24536. eCollection 2021.
4
Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy.肥胖作为造影剂肾病的危险因素。
Angiology. 2021 Mar;72(3):274-278. doi: 10.1177/0003319720969536. Epub 2020 Nov 24.

本文引用的文献

1
Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption.肥胖诱导的肾小球高滤过:其在肾小管钠重吸收发病机制中的作用。
Nephrol Dial Transplant. 2008 Dec;23(12):3946-52. doi: 10.1093/ndt/gfn379. Epub 2008 Jul 12.
2
Statin therapy and contrast-induced nephropathy after primary angioplasty.他汀类药物治疗与原发性经皮冠状动脉介入治疗后对比剂肾病
Int J Cardiol. 2009 May 29;134(3):430-1. doi: 10.1016/j.ijcard.2007.12.122. Epub 2008 May 7.
3
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.N-乙酰半胱氨酸预防造影剂肾病的荟萃分析:采用无监督聚类法解决异质性问题
BMC Med. 2007 Nov 14;5:32. doi: 10.1186/1741-7015-5-32.
4
Obesity, insulin resistance, and renal function.肥胖、胰岛素抵抗与肾功能。
Microcirculation. 2007 Jun-Jul;14(4-5):349-62. doi: 10.1080/10739680701283018.
5
Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.肥胖、炎症与血管疾病:脂肪组织作为内分泌器官的作用
Subcell Biochem. 2007;42:63-91.
6
Obesity, inflammation, and insulin resistance.肥胖、炎症与胰岛素抵抗。
Gastroenterology. 2007 May;132(6):2169-80. doi: 10.1053/j.gastro.2007.03.059.
7
Risk prediction of contrast-induced nephropathy.对比剂肾病的风险预测
Am J Cardiol. 2006 Sep 18;98(6A):27K-36K. doi: 10.1016/j.amjcard.2006.01.022. Epub 2006 Feb 23.
8
F2-isoprostanes as markers of oxidative stress in vivo: an overview.F2-异前列腺素作为体内氧化应激标志物的概述。
Biomarkers. 2005 Nov;10 Suppl 1:S10-23. doi: 10.1080/13547500500216546.
9
Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.血清肌酐水平正常受试者的肾功能评估:年龄和体重指数的影响
Am J Kidney Dis. 2005 Aug;46(2):233-41. doi: 10.1053/j.ajkd.2005.05.011.
10
Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art.造影剂肾病发病机制中的光明与阴影:当前进展
Nephrol Dial Transplant. 2005 Aug;20(8):1542-50. doi: 10.1093/ndt/gfh868.